期刊文献+

炎症性肠病并发低骨量/骨质疏松的危险因素分析 被引量:7

The risk factor for low bone mineral density in patients with inflammatory bowel disease
原文传递
导出
摘要 目的对炎症性肠病(IBD)患者的骨密度状况进行评估,探讨其下降的危险因素。方法通过对IBD患者血液学指标、身高、体重及腰椎骨密度进行测量,并与健康志愿者比较,分析IBD患者骨质疏松的危险因素。结果共收集克罗恩病(CD)77例,溃疡性结肠炎(UC)43例,37例健康志愿者作为对照组。CD组、UC组及对照组的腰椎骨质的T值分别为-1.72±1.20、-1.26±1.12和-0.62±0.87,CD组的T值低于UC组(P=0.045)和对照组(P=0.000),UC组T值低于对照组(P=0.014)。CD组、UC组及对照组的腰椎骨质疏松的发生率分别为23.3%、14.0%和0;CD组的腰椎骨质疏松发生率高于对照组,差异有统计学意义(P=0.003);UC组的腰椎骨质疏松发生率有高于对照组的趋势,但差异无统计学意义(P=0.053)。多元回归分析显示,低体重(BMI≤18.4 kg/m^2)是CD(OR=11.25,95% CI 3.198~39.580,P=0.000)和UC(OR=14.50,95%CI 1.058~88.200,19=0.045)患者骨质疏松的危险因素。年龄、病程、病变部位、CD活动指数(CDAI)、服用糖皮质激素、服用免疫抑制剂、血清25-羟基维生素D浓度等因素与骨质疏松的发生无相关性。结论骨密度下降的发生在IBD患者中较为普遍,低体重是IBD患者骨质丢失的危险因素。 Objective To evaluate the prevalence of low bone mineral density in patients with inflammatory bowel disease(IBD) and to identify its risk factors. Methods A cross-sectional survey was carried out in IBD patients. Anthropometric measures, biochemical markers of nutrition and bone mineral density measurement were completed for these patients as well as healthy control subjects. Results Seventy-seven Crohn's disease (CD) and 43 ulcerative colitis(UC) patients were enrolled, and 37 healthy volunteers were recruited as healthy controls(HC). The T value of CD patients, UC patients and HC was -1.72±1.20, - 1.26 ± 1.12 and -0.62 ±0.87 respectively and the T value of CD patients was significantly lower than that of HC (P = 0. 000). The prevelance of osteoporosis in CD, UC and HC was 23.3% , 14. 0% and 0 respectively. The prevelance of osteoporosis in CD was higher than that in HC (P = 0. 003). Logistic regression analysis indicated that low BMI (BMI ≤ 18.4 kg/m^2) was an independent risk factor for osteoporosis both in CD ( OR = 11.25,95% CI 3. 198 - 39. 580, P = 0. 000 ) and in UC ( OR = 14. 50,95% CI 1. 058 - 88. 200, P = 0. 045 ) patients. Age, disease duration, clinical activity active index (CDAI), oral steroid therapy, immunosuppressant treatment and serum vitamin D concentration were not found to be correlated with osteoporosis in IBD patients. Conclusions Low bone mineral density is common in both CD and UC patients and low BMI is an independent risk factor for osteoporosis in IBD patients.
出处 《中华内科杂志》 CAS CSCD 北大核心 2009年第10期833-836,共4页 Chinese Journal of Internal Medicine
关键词 炎性肠疾病 CROHN病 结肠炎 溃疡性 骨质疏松 Inflammatory bowel disease Crohn disease Colitis,ulcerative Osteoporosis
  • 相关文献

参考文献4

二级参考文献163

  • 1张智海,沈建雄,刘忠厚.中国人骨质疏松症诊断标准回顾性研究[J].中国骨质疏松杂志,2004,10(3):255-262. 被引量:111
  • 2中国人原发性骨质疏松症诊断标准(试行)[J].中国骨质疏松杂志,1999,5(F03):1-3. 被引量:325
  • 3[91]Ohnaka K,Tanabe M,Kawate H,Nawata H,Takayanagi R.Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts.Biochem Biophys Res Commun 2005; 329:177-181
  • 4[92]De Keyser F,Baeten D,Van den Bosch F,Kruithof E,Verbruggen G,Mielants H,Veys E.Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis.Drugs 2004; 64:2793-2811
  • 5[93]Buchman AL.Bones and Crohn's:problems and solutions.Inflamm Bowel Dis 1999; 5:212-227
  • 6[94]Valentine JF,Sninsky CA.Prevention and treatment of osteoporosis in patients with inflammatory bowel disease.Am J Gastroenterol 1999; 94:878-883
  • 7[95]Raisz LG.Clinical practice.Screening for osteoporosis.N Engl J Med 2005; 353:164-171
  • 8[96]Kornbluth A,Hayes M,Feldman S,Hunt M,Fried-Boxt E,Lichtiger S,Legnani P,George J,Young J.Do guidelines matter? Implementation of the ACG and AGA osteoporosis screening guidelines in inflammatory bowel disease (IBD) patients who meet the guidelines' criteria.Am J Gastroenterol 2006; 101:1546-1550
  • 9[97]Lichtenstein GR,Sands BE,Pazianas M.Prevention and treatment of osteoporosis in inflammatory bowel disease.Inflamm Bowel Dis 2006; 12:797-813
  • 10[98]Leib ES,Binkley N,Bilezikian JP,Kendler DL,Lewiecki EM,Petak SM.Position Development Conference of the International Society for Clinical Densitometry.Vancouver,BC,July 15-17,2005.J Rheumatol 2006; 33:2319-2321

共引文献829

同被引文献78

  • 1冯家烜,戴生明.补充维生素D防治多种慢性疾病的研究进展[J].中国临床营养杂志,2008,16(4):259-264. 被引量:3
  • 2昊佳愉,孙菁,袁耀宗.炎症性肠病患者骨密度降低的多因素分析[J].中华消化杂志,2007,27(2):90-94. 被引量:12
  • 3Marques CD,Dantas AT,Fragoso TS,et al.The importance of vitamin D levels in autoimmune diseases.Rev Bras Reumatol,2010,50:67-80.
  • 4Lagishetty V,Misharin AV,Liu NQ,et al.Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis.Endocrinology,2010,151:2423-2432.
  • 5Bouillon R,Carmeliet G,Verlinden L,et al.Vitamin D and human health:lessons from vitamin D receptor null mice.Endocr Rev,2008,29:726-776.
  • 6Miheller P,Muzes G,Hritz I,et al.Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients.Inflamm Bowel Dis,2009,15:1656-1662.
  • 7Tilg H,Moschen AR,Kaser A,et al.Gut,inflammation and osteoporosis:basic and clinical concepts.Gut,2008,57:684-694.
  • 8欧阳钦,胡品津,钱家鸣,郑家驹,胡仁伟.对我国炎症性肠病诊断治疗规范的共识意见[J].胃肠病学,2007,12(8):488-495. 被引量:751
  • 9Baumgart DC, Sandborn WJ. Crohn′s disease[J].Lancet, 2012, 380(9853):1590-1605.
  • 10Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn′s and colitis epidemiology study[J].Gastroenterology, 2013, 145(1):158-165.e2.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部